HeartLung AI

One Scan. Many Answers.

Innovation Hub

• Explore HeartLung.AI’s next-generation AI-CVD research, including Agatston-2.0 coronary calcium quantification, plaque density profiling, and opportunistic cardiovascular risk prediction from chest X-rays.

• Discover how these emerging technologies are being studied to identify non-calcified plaque burden, refine risk stratification across calcium-score categories, and extract additional cardiovascular insight from routine imaging.

The research and technologies shown are investigational and under development. They are not available for commercial use, have not been cleared or approved by the FDA, and are not for sale in the United States or elsewhere.

​

Customer 1:1 Meetings

• Share your preferred dates, times, and discussion topics, including clinical validation, research collaboration, cardiovascular risk stratification, plaque analysis, or workflow integration, and we will connect you with the appropriate HeartLung.AI scientific or leadership team member. Use the “Contact Us” form to request a meeting at AHA 2026, Booth 641.

​

Meet the HeartLung.AI Team

• Get a guided look at the AI-CVD interface, explore case-based workflows, and discuss how HeartLung.AI can support cardiovascular insights from CT and chest X-ray imaging. Our team will tailor the conversation to your clinical, research, or strategic interests.